CHRISTIAN PRICE: Open Payments
NPI 1760101893 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 73 payments from 23 companies in 2025. Trend: 2023 $1,443 · 2024 $1,168 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $227 |
| Daiichi Sankyo Inc. | 11 | $204 |
| Novartis Pharmaceuticals Corporation | 10 | $165 |
| Incyte Corporation | 5 | $113 |
| Eisai Inc. | 4 | $91 |
| PFIZER INC. | 3 | $88 |
| SOBI, INC | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Exelixis Inc. | 2 | $44 |
Products named: DATROWAY, TALVEY, MONJUVI, Lenvima, ERLEADA, PLUVICTO, XTANDI, Enhertu.
Industry payments across PA — which companies pay providers there.
